126 related articles for article (PubMed ID: 23294903)
1. Oxidized high-density lipoprotein reduces blood clot firmness.
Talens S; Malfliet JJ; Leebeek FW; Rijken DC
J Thromb Haemost; 2013 Mar; 11(3):561-3. PubMed ID: 23294903
[No Abstract] [Full Text] [Related]
2. Effects of low-density lipoproteins on blood coagulation and fibrinolytic activity.
Azizova OA; Roitman EV; Dement'eva II; Nikitina NA; Gagaeva EV; Lopukhin YM
Bull Exp Biol Med; 2000 Jun; 129(6):541-4. PubMed ID: 11022243
[TBL] [Abstract][Full Text] [Related]
3. Coupling of fibrin with low density lipoproteins.
Skrzydlewski Z
Acta Med Acad Sci Hung; 1976; 33(2):171-7. PubMed ID: 199019
[TBL] [Abstract][Full Text] [Related]
4. [Hyperlipoproteinemia and fibrin stabilization using blood factor 13].
Zöller H; Fromme K; Gross W
Med Welt; 1974 Aug; 33(34):1303-4. PubMed ID: 4369583
[No Abstract] [Full Text] [Related]
5. Fibrinolysis and the control of blood coagulation.
Chapin JC; Hajjar KA
Blood Rev; 2015 Jan; 29(1):17-24. PubMed ID: 25294122
[TBL] [Abstract][Full Text] [Related]
6. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
7. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
8. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.
Ostrowski SR; Berg RM; Windeløv NA; Meyer MA; Plovsing RR; Møller K; Johansson PI
PLoS One; 2013; 8(3):e59368. PubMed ID: 23555024
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
[TBL] [Abstract][Full Text] [Related]
10. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.
Lau YC; Xiong Q; Lip GY; Blann AD
Ann Med; 2016; 48(4):275-81. PubMed ID: 27043881
[TBL] [Abstract][Full Text] [Related]
11. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Ambrose JA
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):75-9. PubMed ID: 19815816
[TBL] [Abstract][Full Text] [Related]
12. The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.
Lai BF; Zou Y; Brooks DE; Kizhakkedathu JN
Biomaterials; 2010 Aug; 31(22):5749-58. PubMed ID: 20435346
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Cyanosis and Thromboelastometry (ROTEM) in Children With Congenital Heart Defects: A Retrospective Cohort Study.
Laskine-Holland ML; Kahr WH; Crawford-Lean L; Humpl T; Honjo O; Foreman C; Jain M; O'Leary JD
Anesth Analg; 2017 Jan; 124(1):23-29. PubMed ID: 27861436
[TBL] [Abstract][Full Text] [Related]
14. [Blood coagulation and the physico-chemical properties of the fibrin-thrombocytic structure of the clot in patients with post-infarct cardiosclerosis].
Mikhalev VV
Ter Arkh; 1971 Aug; 43(8):99-102. PubMed ID: 5151785
[No Abstract] [Full Text] [Related]
15. Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein.
Siudut J; Ząbczyk M; Wołkow P; Polak M; Undas A; Jawień J
Vascul Pharmacol; 2022 Jun; 144():106977. PubMed ID: 35283275
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and fibrinolysis after injury.
Flute PT
J Clin Pathol Suppl (R Coll Pathol); 1970; 4():102-9. PubMed ID: 5293379
[No Abstract] [Full Text] [Related]
17. On fibrinolysis and coagulation during parturition and menstruation.
Hahn L
Acta Obstet Gynecol Scand Suppl; 1974; 28():7-40. PubMed ID: 4599650
[No Abstract] [Full Text] [Related]
18. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans.
Spiel AO; Mayr FB; Firbas C; Quehenberger P; Jilma B
J Thromb Haemost; 2006 Feb; 4(2):411-6. PubMed ID: 16420574
[TBL] [Abstract][Full Text] [Related]
19. Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor.
Shenkman B; Einav Y; Livnat T; Budnik I; Martinowitz U
Int J Lab Hematol; 2015 Aug; 37(4):521-9. PubMed ID: 25651468
[TBL] [Abstract][Full Text] [Related]
20. The coagulation system in humans.
Chan AK; Paredes N
Methods Mol Biol; 2013; 992():3-12. PubMed ID: 23546701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
